Skip to main content
. 2011 Oct 5;2011(10):CD006423. doi: 10.1002/14651858.CD006423.pub2

Analysis 12.10.

Comparison 12 Liraglutide 1.8 mg daily versus thiazolidinedione, Outcome 10 Post‐prandial glucose (mmol/L).

Post‐prandial glucose (mmol/L)

Study Description Liraglutide 1.8 mg daily Rosiglitazone 4 mg QD Comments
L ‐ LEAD 1 Marre 2009 average of values obtained 90 min after breakfast, lunch and evening meal ‐2.7 mmol/L ‐1.8 mmol/L P = 0.0022 1.8 mg versus rosiglitazone